Search Results for "Pain"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for Pain. Results 151 to 160 of 874 total matches.
Ashwagandha Supplements
The Medical Letter on Drugs and Therapeutics • Mar 08, 2021 (Issue 1619)
as winter cherry
and Indian ginseng, are widely promoted now in the
US for treatment of pain, anxiety ...
Ashwagandha is an herb extracted from the roots of
an evergreen shrub (Withania somnifera) found in
India that has been used as a "tonic" for centuries.
No specific constituent has been identified as an
active ingredient. Herbal supplements containing
ashwagandha, which is also known as winter cherry
and Indian ginseng, are widely promoted now in the
US for treatment of pain, anxiety, stress, fatigue, sleep
disturbances, cognitive decline, diabetes, arthritis,
male infertility, and various cancers.
In Brief: Heat and Transdermal Fentanyl
The Medical Letter on Drugs and Therapeutics • Aug 10, 2009 (Issue 1318)
system for patients with chronic
pain
1
but it has some drawbacks. One is that exposing
the patch ...
Transdermal fentanyl (Duragesic, and others) offers a convenient delivery system for patients with chronic pain1 but it has some drawbacks. One is that exposing the patch to heat, either from an external source, increased exertion or possibly high fever, could increase release of the drug, which might lead to an overdose and fatal respiratory depression.2 A recent article in the NY Times about this problem may have aroused the concerns of some patients using the patches.3First approved for marketing by the FDA in 19914, transdermal fentanyl provides continuous delivery of the drug for about 3...
FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine
The Medical Letter on Drugs and Therapeutics • Jan 11, 2021 (Issue 1615)
who received placebo.1
ADVERSE EFFECTS — Injection-site pain, fatigue, chills,
headache, muscle ...
The FDA has issued an Emergency Use Authorization
(EUA) for the Pfizer-BioNTech mRNA-based vaccine
for prevention of COVID-19 in persons ≥16 years old.
In Brief: Restrictions on Essure
The Medical Letter on Drugs and Therapeutics • May 21, 2018 (Issue 1547)
and fallopian tube perforation, migration of the device to the
abdominal or pelvic cavity, persistent pain ...
Essure (Bayer) is the only nonsurgical, permanent contraceptive available in the US. The coil-like devices are placed hysteroscopically in both fallopian tubes and, after several months, scar tissue causes tubal occlusion.1 In 2016, the FDA required Bayer to revise the device's labeling to include a patient decision checklist and a boxed warning about the risks of uterine and fallopian tube perforation, migration of the device to the abdominal or pelvic cavity, persistent pain, and hypersensitivity reactions. Some women were apparently not being informed of these risks before implantation of...
COVID-19 Update: Booster Dose of the Pfizer Vaccine for Children 5-11 Years Old
The Medical Letter on Drugs and Therapeutics • Jun 13, 2022 (Issue 1652)
),
injection-site pain, swelling, and erythema, fatigue,
headache, muscle pain, and chills were common ...
The FDA has expanded its Emergency Use Authorization for the mRNA COVID-19 vaccine manufactured by Pfizer/BioNTech (Comirnaty) to include administration of a booster dose in children 5-11 years old who completed a primary series of the Pfizer vaccine ≥5 months previously.
Anastrozole for Metastatic Breast Cancer
The Medical Letter on Drugs and Therapeutics • Jul 05, 1996 (Issue 978)
, headache, hot flushes and pain (including bone pain and
back pain) have occurred in 10% to 15%. Dyspnea ...
Anastrozole (Arimidex - Zeneca), a selective nonsteroidal aromatase inhibitor, has been approved by the US Food and Drug Administration (FDA) for treatment of postmenopausal women with advanced breast cancer that has progressed during treatment with tamoxifen (Nolvadex, and others).
Miconazole (Oravig) for Oropharyngeal Candidiasis
The Medical Letter on Drugs and Therapeutics • Nov 29, 2010 (Issue 1352)
effects reported in clinical trials of buccal miconazole
were diarrhea, nausea, upper abdominal pain ...
The FDA has approved a buccal tablet formulation of
miconazole (Oravig – Strativa) for local treatment of
oropharyngeal candidiasis in adults. Miconazole has
been available for many years in topical formulations
for treatment of superficial fungal infections and vulvovaginal
candidiasis.
Botulinum Toxin for Chronic Migraine
The Medical Letter on Drugs and Therapeutics • Jan 24, 2011 (Issue 1356)
of botulinum
toxin A injected on the day of enrollment. The
reduction in the number of pain days ...
The FDA has approved injection of onabotulinumtoxinA
(Botox – Allergan) for prevention of
headaches in adult patients with chronic migraine (≥15
headache days/month for ≥3 months). It is the first
drug approved for treatment of this indication. Botox is
also FDA-approved for treatment of upper limb spasticity,
axillary hyperhidrosis, cervical dystonia, blepharospasm
and strabismus, and for cosmetic
reduction of wrinkles.
Expanded Table: Some Vaccines for Travelers (online only)
The Medical Letter on Drugs and Therapeutics • Nov 19, 2018 (Issue 1560)
▶ Injection-site pain is common; swelling
and erythema can occur
▶ Mild systemic complaints ...
View the Expanded Table: Some Vaccines for Travelers
Adult Immunization
The Medical Letter on Drugs and Therapeutics • Oct 17, 2022 (Issue 1661)
with administration of Td or Tdap, but
they are usually mild. Fever and injection-site pain
have been more frequent ...
The Advisory Committee on Immunization Practices
(ACIP) recommends use of certain vaccines in adults
residing in the US. Routine childhood immunization
has reduced the overall incidence of some of
these vaccine-preventable diseases, but many
adults remain susceptible. Recommendations for
vaccination against COVID-19, seasonal influenza,
and monkeypox and vaccination of travelers have
been reviewed separately.